LDLR and familial hyperaldosteronism: The ability to detect the full spectrum of mutations in LDLR is critical in obtaining a molecular diagnosis for FH, especially since up to 10% or more of such mutations are large-scale CNVs rather than small-scale DNA sequence variants, depending on the cohort and ascertainment (18).